Skip to main content

INTRAVENOUS B12 INJECTION PRECAUTION & PREVENTION TO BE CONSIDERED

 




Giving vitamin B12 parenterally? 🤔 Which electrolyte should you check first? Answer: ⬇️ Potassium. 🔎 And why does it matter? Because rapid correction of severe B12 deficiency can trigger a surge in bone marrow activity and red blood cell production. As the marrow suddenly starts making new cells aggressively, potassium shifts intracellularly and serum levels can fall fast. That means: ⚠️ Hypokalemia can develop or worsen which can lead to: • Cardiac arrhythmias • Muscle weakness • QT prolongation • In severe cases, sudden cardiovascular instability This is a classic board-style pearl that many clinicians forget because B12 feels “benign.” But in profoundly deficient patients—especially those with severe megaloblastic anemia—repletion is metabolically active treatment. Clinical Pearl: Before parenteral B12, always think: 🧪 Check potassium ❤️ Prevent hypokalemic arrhythmia Medicine is often about anticipating the treatment complication before it happens. 💬 Did you know this one? Any other clinical nutrition pearls you can share or that I should do a post on next?

Comments

Popular posts from this blog

Curated Compendium of Drug Discovery

  Drug discovery is a multidisciplinary process that integrates biology, chemistry, pharmacology , and cutting-edge technologies to identify and develop new therapeutic agents. From target identification to lead optimization and clinical evaluation, each stage requires precision, innovation, and collaboration. A curated list of drug discovery resources provides researchers, students, and professionals with a structured pathway to explore advancements, tools, and strategies that shape modern therapeutics. This compilation serves as a gateway to understanding the evolution of drug discovery, recent breakthroughs, and future directions, fostering knowledge-sharing and accelerating translational research. Databases and Chemical Libraries General Compound Libraries DrugBank  - Comprehensive data on approved and investigational drugs. ZINC  - Free compounds for screening. ChemSpider  - Chemical structures and data. DrugSpaceX  - Chemical and biological spaces. Mcule ...

Understanding NMR Spectroscopy and Chemical Shift Ranges for Functional Groups

  Nuclear Magnetic Resonance ( NMR ) spectroscopy is one of the most powerful analytical tools in pharmaceutical chemistry. It helps chemists determine the structure, purity, and chemical environment of molecules by analyzing the behavior of nuclei (commonly ¹H or ¹³C ) when exposed to a strong magnetic field. In proton NMR ( ¹H-NMR ), the chemical shift (δ, in ppm) provides information about the type of hydrogen atoms present in a compound and their surrounding electronic environment. Depending on nearby atoms and functional groups, signals appear in specific regions of the spectrum — often referred to as upfield (shielded, lower δ values) or downfield (deshielded, higher δ values). The image above summarizes the characteristic δ ranges for different functional groups in ¹H-NMR. Let us break it down systematically: 1. Downfield Region (δ 12 – 6 ppm) Hydrogens in this region are strongly deshielded due to electronegative atoms or Ï€-bond systems. Carboxylic Acids (–COOH) : δ 1...

Pushing the boundaries of computational drug discovery at Isomorphic Labs

  The Isomorphic Labs Drug Design Engine (IsoDDE) has unlocked a new frontier in in-silico drug design, representing a significant evolution beyond AlphaFold 3. What IsoDDE delivers: 🔹 Massive accuracy leap on unconstrained structure prediction The engine more than doubles AlphaFold 3's accuracy on extremely challenging protein-ligand prediction tasks — including systems far outside the training distribution. 🔹 Best-in-class binding affinity prediction IsoDDE predicts how strongly small molecules bind to targets with accuracy that exceeds gold-standard physics-based methods, at a fraction of the computational cost and time. 🔹 Blind identification of novel binding pockets Even without existing structural data, the engine reveals previously unseen binding sites — just from an amino acid sequence — enabling drug designers to explore entirely new chemical action spaces. 🔹 Expanded support for complex biologics Beyond small molecules, the engine boosts prediction fidelity for...